Leverage Factor

The Disease Control Priorities Project reports on the cost effectiveness of intervention.

Project Cost Real world outcome Outcome estimates Economic value in Western terms Leverage Factor
Case finding and treatment $15 1 DALY saved - $90,000 6,000
Eflornithine for second stage treatment $20 1 DALY saved Sub-Saharan Africa target population $90,000 4,500
Melarsoprol for second stage treatment $10 1 DALY saved Sub-Saharan Africa target population $90,000 9,000

We focus on identification and the primary stage of the disease, and do not incorporate the second stage treatment into the Leverage Factor.

Leverage Factor

6,000